Laurus Labs · NSE: LAURUSLABS · BSE: 540222
Q4 FY21 results · Jan–Mar 2021
Laurus Labs reported revenue from operations of ₹1,411.93 crore (up 68.3% from Q4 FY20) and net profit of ₹296.92 crore (up 169.6% from Q4 FY20) for Q4 FY21 (Jan–Mar 2021), on a consolidated basis.
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,411.93 | 839.14 | +68.3% | 1,288.42 | +9.6% |
| Other income | 4.52 | 1.68 | +168.9% | 6.93 | −34.8% |
| Total income | 1,416.45 | 840.82 | +68.5% | 1,295.35 | +9.3% |
| Profit before tax | 401.17 | 126.74 | +216.5% | 364.16 | +10.2% |
| Net profit for the period | 296.92 | 110.15 | +169.6% | 272.85 | +8.8% |
| EPS, basic (₹) | 5.53 | 10.32 | not comparable | 5.09 | +8.6% |
| Net margin (%) | 21.0 | 13.1 | 21.2 |
| Item | Q4 FY21 | Q4 FY20 | YoY | Q3 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,398.74 | 829.23 | +68.7% | 1,272.27 | +9.9% |
| Other income | 5.72 | 1.62 | +252.0% | 8.54 | −33.0% |
| Total income | 1,404.46 | 830.85 | +69.0% | 1,280.81 | +9.7% |
| Profit before tax | 396.38 | 128.95 | +207.4% | 356.92 | +11.1% |
| Net profit for the period | 292.78 | 112.53 | +160.2% | 266.96 | +9.7% |
| EPS, basic (₹) | 5.46 | 10.54 | not comparable | 4.98 | +9.6% |
| Net margin (%) | 20.9 | 13.6 | 21.0 |
Consolidated
- Filed with BSE
- 29 Apr 2021, 20:07 IST
- Board meeting
- 29 Apr 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 29 Apr 2021, 20:07 IST
- Board meeting
- 29 Apr 2021
- Period
- 01 Jan 2021 to 31 Mar 2021
- Review status
- Audited
- Source
- XBRL filing on BSE